Voloridge Investment Management
MRTX

Voloridge Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Voloridge Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,607
Closed -$1.16M – 1552
2023
Q3 		$1.16M Sell
26,607
-379,428
-93% -$13.5M 0.01% 1067
2023
Q2 		$14.7M Sell
406,035
-272,623
-40% -$11.2M 0.07% 369
2023
Q1 		$25.2M Buy
678,658
+524,038
+339% +$23.6M 0.13% 240
2022
Q4 		$7.01M Buy
154,620
+130,363
+537% +$8.44M 0.04% 539
2022
Q3 		$1.69M Sell
24,257
-375,923
-94% -$27.8M 0.01% 1031
2022
Q2 		$26.9M Buy
400,180
+339,781
+563% +$21.6M 0.14% 217
2022
Q1 		$4.97M Buy
+60,399
New +$6.18M 0.03% 641
2021
Q3 		– Sell
-4,622
Closed -$747K – 1930
2021
Q2 		$747K Sell
4,622
-19,496
-81% -$3.13M 0.01% 1341
2021
Q1 		$4.13M Buy
24,118
+9,948
+70% +$1.97M 0.03% 590
2020
Q4 		$3.11M Buy
14,170
+2,123
+18% +$459K 0.03% 592
2020
Q3 		$2M Buy
+12,047
New +$1.65M 0.02% 725
2019
Q3 		– Sell
-29,071
Closed -$2.99M – 1251
2019
Q2 		$2.99M Sell
29,071
-6,906
-19% -$538K 0.08% 254
2019
Q1 		$2.64M Buy
+35,977
New +$2.45M 0.08% 245

Other funds holding MRTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return

Voloridge Investment Management's MRTX Position: Q4 2023 in Review

Voloridge Investment Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2023, closing a stake of 26,607 shares — an estimated $1.16M sold.

Voloridge Investment Management first reported a position in MRTX in Q1 2019 and held it in 13 quarters. The position peaked at $26.9M in Q2 2022. 217 funds tracked by Wall St. Rank hold MRTX as of Q4 2023.

  • Voloridge Investment Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 26,607 Mirati Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $1.16M.
  • Voloridge Investment Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Voloridge Investment Management's Mirati Therapeutics, Inc. Common Stock position peaked at $26.9M in Q2 2022.
  • 217 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.